MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Neuronal nicotinamide-N-methyltransferase (NNMT) in Parkinson’s disease

K. Schmeisser, A. Parker (Montreal, QC, Canada)

Meeting: 2016 International Congress

Abstract Number: 652

Keywords: Aging, Dopaminergic neurons, Drug-induced parkinsonism(DIP), Neuroprotective agents

Session Information

Date: Tuesday, June 21, 2016

Session Title: Genetics (PD and Non-PD)

Session Time: 12:30pm-2:00pm

Objective: Understanding the role of NNMT in initiation and progression of Parkinson’s disease (PD).

Background: 10-15% of all PD cases are caused by genetic factors, whereas environmental influences might also be of major importance. Epidemiological studies have linked the exposure to industrial toxicants to developing PD. NNMT, a niacin-metabolizing enzyme, might be a key factor in PD since research has shown that NNMT expression is significantly increased in the brains of post-mortem PD patients. NNMT might be involved in causing PD by environmental toxins, similar to the pro-toxin MPTP, which after its conversion to the highly poisonous MPP+ causes PD symptoms. NNMT might also be involved in the “toxification” processes of harmless precursors as its metabolic product, 1-methylnicotinamide (MNA), has striking similarities to the structure of MPP+. Interestingly, MNA has been shown to exert both neurotoxic and neuroprotective effects. This could be explained by a hormetic dose-dependent adaptive response mechanism.

Methods: Transgenic Caenorhabditis elegans were generated that express NNMT in the dopaminergic neurons. GFP was expressed in the dopaminergic neurons of these strains to follow their degeneration in vivo by using fluorescence microscopy. We also analyzed dopamine-dependent behaviors like locomotion and sensing of food or chemicals. All analyses were done using animals at different ages to monitor age-dependent neurodegeneration. Environmental toxins were evaluated for their ability to induce PD-like symptoms in an NNMT-dependent manner, and a genetic screen was performed to evaluate the mechanism behind neuronal NNMT action.

Results: We found that enzymatic activity of NNMT in dopaminergic neurons increases degeneration and influences dopamine-dependent behaviors in C. elegans. Strikingly, it also has neuroprotective effects, as shown by increased resistance against environmental toxins, and increases lifespan of the worms. The genetic screen revealed genes involved in stress response and autophagy that influence these phenotypes.

Conclusions: Moderate neuronal NNMT acts most likely as a double-edged sword – by exerting slightly toxic effects it stimulates a transcriptional adaptive response that influences neuronal autophagy and stress defense mechanisms to finally reach a state in which the cell becomes more resistant against environmental influences that could promote PD.

To cite this abstract in AMA style:

K. Schmeisser, A. Parker. Neuronal nicotinamide-N-methyltransferase (NNMT) in Parkinson’s disease [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/neuronal-nicotinamide-n-methyltransferase-nnmt-in-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/neuronal-nicotinamide-n-methyltransferase-nnmt-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley